Susan Seedman, M.D.August 30, 2024

FDA 483 - Susan Seedman, M.D. - August 30, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Susan Seedman, M.D.

Record Details

An FDA inspection of Susan Seedman, M.D. in Rio Rancho, NM, revealed significant deficiencies in clinical trial conduct. Observations included failures to adhere to investigational plans, specifically regarding subject eligibility and timely reporting of serious adverse events. Additionally, informed consent documents lacked crucial information about compensation for research-related injuries.

Company: Susan Seedman, M.D.
Inspection Date: August 30, 2024
Product Type: Drugs
Office: Denver District Office
Person: Logan M. Jones

Open in Dashboard

ID · 333b9f32-307b-4151-983e-432665248bc6